Does Insurance Cover Zepbound? (2026 Guide)
It depends on your plan and diagnosis. Zepbound (tirzepatide) is FDA approved for chronic weight management and, since 2024, for obstructive sleep apnea (OSA) in adults with obesity. Many employer and marketplace plans exclude weight-loss drugs entirely, so coverage is often easier through the OSA indication, and plans usually require prior authorization and a documented BMI or OSA diagnosis.
What Decides Whether It Is Covered
- Whether your plan covers weight-loss drugs at all. Many employer and marketplace plans exclude weight-management medications, so Zepbound for weight loss alone may not be covered even with a qualifying BMI.
- Your diagnosis. Coverage is often easier for the obstructive sleep apnea (OSA) indication in adults with obesity than for weight loss alone, since OSA is treated as a medical condition.
- Prior authorization. Plans that do cover it typically require prior authorization with a documented BMI or a confirmed OSA diagnosis before approving.
- Commercial vs Medicare vs Medicaid. Medicare Part D does not cover weight-loss drugs, though it may cover the OSA indication depending on the plan. Medicaid coverage of weight-loss drugs varies by state.
What You Would Pay
| Situation | What you pay |
|---|---|
| Commercial plan that covers it, with prior authorization | A copay or coinsurance, often reduced by the manufacturer commercial copay card |
| LillyDirect self-pay vials | Roughly $349 to $499 per month, depending on dose |
| No coverage / cash price | About $1,060 per month |
How to Lower What You Pay
Use the OSA indication if it applies
If you have obstructive sleep apnea with obesity, coverage is often easier through that medical indication than for weight loss alone. Ask your prescriber to document the OSA diagnosis when requesting coverage.
Use the manufacturer copay card (commercial plans)
If you have commercial insurance, the Zepbound copay program can lower your covered copay. It cannot be used with Medicare or Medicaid.
Compare LillyDirect self-pay if you are not covered
If your plan excludes weight-loss drugs, LillyDirect self-pay vials (roughly $349 to $499 per month) can cost far less than the roughly $1,060 monthly cash price.
Make sure prior authorization is submitted, and appeal a denial
A denial is often a missing prior authorization or a weight-loss exclusion. Your prescriber can submit the prior authorization, and an appeal through the OSA indication can sometimes turn a denial around.
Check your own plan in seconds
Enter your insurer and plan name, or upload your Summary of Benefits and Coverage for the highest-confidence answer, and our free checker shows whether your plan covers Zepbound, any prior-authorization rule, and your likely cost.
Check my coverageDenied or hit with a big pharmacy bill? We'll look at it.
If your plan denied Zepbound or you were charged more than you should have been, a missing prior authorization or an appeal through the OSA indication can often turn it around. CareRoute Bill Defense can handle the appeal and any resulting bill. No fee unless we save you money.
Get Bill Defense on itFrequently Asked Questions
Does insurance cover Zepbound?
It depends on your plan and diagnosis. Many employer and marketplace plans exclude weight-loss drugs entirely, so Zepbound (tirzepatide) may not be covered for weight loss alone. Coverage is often easier through the obstructive sleep apnea (OSA) indication in adults with obesity. Plans that do cover it usually require prior authorization and a documented BMI or OSA diagnosis.
Why is Zepbound so expensive?
Zepbound is a brand-name GLP-1 and GIP medication without generic competition, which keeps the list price high, about $1,060 per month at the cash price. If your plan does not cover it, LillyDirect self-pay vials (roughly $349 to $499 per month) can cost far less. What you pay with coverage depends on your plan's cost sharing and any copay card.
Does Medicare cover Zepbound?
Medicare Part D does not cover weight-loss drugs, so Zepbound is not covered for weight loss alone. It may cover the obstructive sleep apnea (OSA) indication depending on the plan. Check your specific Part D plan's formulary and any prior-authorization rules.
How can I lower the cost of Zepbound?
If you have obstructive sleep apnea with obesity, coverage is often easier through that indication, so ask your prescriber to document it. With commercial insurance, the manufacturer copay card can lower your covered copay (it cannot be used with Medicare or Medicaid). If you are not covered, LillyDirect self-pay vials (roughly $349 to $499 per month) can cost far less than the roughly $1,060 cash price. Make sure any required prior authorization is submitted.
My Zepbound was denied. Can I appeal?
Yes. Denials are common, often for a missing prior authorization or a weight-loss exclusion, and they are appealable. An appeal through the obstructive sleep apnea (OSA) indication can sometimes turn a denial around. CareRoute Bill Defense can help with the appeal and any resulting bill, with no fee unless we save you money.
Related
Sources
- FDA approvals for tirzepatide (Zepbound) for chronic weight management and, in 2024, for obstructive sleep apnea in adults with obesity
- Health-plan formularies and prior-authorization policies for weight-management and GLP-1 drugs; Medicare Part D weight-loss drug exclusion; state Medicaid coverage variation; manufacturer self-pay (LillyDirect) and copay-assistance terms
Coverage, indications, and prices vary by plan and change often. This page is general information, not medical, legal, or financial advice. Confirm coverage with your plan. Last updated September 24, 2026.